The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Dr. Katrin Rupalla

Dr. Katrin Rupalla is a member of the CDDF Board of Directors

Dr. Katrin Rupalla has more than 25 years of experience in research & drug development, primarily in the areas of oncology, immunology and neurology. She worked in several leadership positions in the pharmaceutical industry at Lundbeck, BMS, Celgene and Roche. Until end 2021, she was the SVP Global Regulatory, Medical Documentation and RD Quality at Lundbeck.

Prior to joining Lundbeck, she spent 7 years at BMS as VP Global Head of Regulatory Oncology, VP, Head of Development China, and VP, head of EU Regulatory Science.

Dr. Rupalla is a certified pharmacist and obtained her PhD from Philipps University of Marburg, Germany in CNS Pharmacology. She holds an MBA from Jones International University and a NED Diploma from Financial Times.

View current disclosure here

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70